Source: Biospectrum Asia

Neograft: VGS acquires Intellectual Property developed by Kipsbay Medical Inc

"Strengthening our IP portfolio, coupled with the evolution of our clinical data, position VGS as a global leader in the field of advanced vascular engineering"

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Jon McGrath's photo - President & CEO of Neograft

President & CEO

Jon McGrath

CEO Approval Rating

82/100

Read more